Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MDS Inc. was a prominent Canadian global life sciences company that operated as a major service provider to the pharmaceutical and biotechnology industries. The company was best known for its diverse divisions, including MDS Pharma Services, which provided contract research organization (CRO) services, and MDS Nordion, a leader in medical isotopes and radiopharmaceuticals. Additionally, its MDS Sciex division was a pioneer in mass spectrometry technology. Following a series of strategic divestitures in the late 2000s, the company's various business units were sold to major industry players such as Danaher and Ricerca Biosciences, and the remaining entity was eventually rebranded as Nordion Inc.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mobile Digital Systems.